Independent association between nonalcoholic fatty liver disease and cardiovascular disease: A systematic review and meta-analysis

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Lu, Hongyun ^a   Liu, Hong ^a   Hu, Fang ^a   Zou, Lingling ^a   Luo, Shunkui ^a   Sun, Liao ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROTIC PLAQUE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CORONARY ARTERY ATHEROSCLEROSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW;

EID: 84877301131     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/124958     Document Type: Review

References (41)

1. Farrell G. C., Larter C. Z., Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006 43 2 S99 S112 2-s2.0-33644547706 10.1002/hep.20973
2. Browning J. D., Szczepaniak L. S., Dobbins R., Nuremberg P., Horton J. D., Cohen J. C., Grundy S. M., Hobbs H. H., Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004 40 6 1387 1395 2-s2.0-10644220306 10.1002/hep.20466 (Pubitemid 39657013)
3. Welsh J. A., Karpen S., Vos M. B., Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010. Journal of Pediatrics 2013 162 3 496 500 10.1016/j.jpeds.2012.08.043
4. Bedogni G., Miglioli L., Masutti F., Tiribelli C., Marchesini G., Bellentani S., Prevalence of and risk factors for nonalcoholic fatty liver disease: the dionysos nutrition and liver study. Hepatology 2005 42 1 44 52 2-s2.0-21344449292 10.1002/hep.20734 (Pubitemid 40911310)
5. Hu X., Huang Y., Bao Z., Prevalence and factors associated with nonalcoholic fatty liver disease in shanghai work-units. BMC Gastroenterol 2012 12, article 123
6. Ying X., Jiang Y., Qian Y., Jiang Z., Song Z., Zhao C., Association between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in Chinese adults. Iranian Journal of Public Health 2012 41 1 45 49
7. Musso G., Gambino R., Bo S., Cassader M., Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with adult treatment panel III criteria in nonobese nondiabetic subjects. Diabetes Care 2008 31 562 568 2-s2.0-64349123094 10.2337/dc08-0223
8. Hamaguchi M., Takeda N., Kojima T., Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome. World Journal of Gastroenterology 2012 18 13 1508 1516 10.3748/wjg.v18.i13.1508
9. Targher G., Marra F., Marchesini G., Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia 2008 51 11 1947 1953 2-s2.0-53549112749 10.1007/s00125-008-1135-4
10. Choi S. Y., Kim D., Kim H. J., Kang J. H., Chung S. J., Park M. J., Kim Y. S., Kim C. H., Choi S. H., Kim W., Kim Y. J., Yoon J. H., Lee H. S., Cho S. H., Sung M. W., Oh B. H., The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. American Journal of Gastroenterology 2009 104 8 1953 1960 2-s2.0-68349155831 10.1038/ajg.2009.238
11. Treeprasertsuk S., Lopez-Jimenez F., Lindor K. D., Nonalcoholic fatty liver disease and the coronary artery disease. Digestive Diseases and Sciences 2011 56 1 35 45 2-s2.0-79151478841 10.1007/s10620-010-1241-2
12. Targher G., Bertolini L., Padovani R., Rodella S., Zoppini G., Zenari L., Cigolini M., Falezza G., Arcaro G., Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006 29 6 1325 1330 2-s2.0-33746421488 10.2337/dc06-0135 (Pubitemid 44125930)
13. Villanova N., Moscatiello S., Ramilli S., Bugianesi E., Magalotti D., Vanni E., Zoli M., Marchesini G., Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005 42 2 473 480 2-s2.0-23044512117 10.1002/hep.20781 (Pubitemid 41061101)
14. Kim D., Choi S. Y., Park E. H., Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology 2012 56 2 605 613 10.1002/hep.25593
15. Sung K. C., Wild S. H., Kwag H. J., Byrne C. D., Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10, 153 people. Diabetes Care 2012 35 11 2359 2364 10.2337/dc12-0515
16. Kim B. J., Kim N. H., Kim B. S., Kang J. H., The association between nonalcoholic fatty liver disease, metabolic syndrome and arterial stiffness in nondiabetic, nonhypertensive individuals. Cardiology 2012 123 1 54 61 10.1159/000341248
17. Yilmaz Y., Senates E., Ayyildiz T., Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome. European Journal of Clinical Investigation 2012 42 4 411 418 10.1111/j.1365-2362.2011.02597.x
18. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Journal of the American Medical Association 2001 285 19 2486 2497 2-s2.0-0035897696
19. Li W., Ma D., Liu M., Liu H., Feng S., Hao Z., Wu B., Zhang S., Association between metabolic syndrome and risk of stroke: a meta-analysis of cohort studies. Cerebrovascular Diseases 2008 25 6 539 547 2-s2.0-45549087871 10.1159/000131672 (Pubitemid 351861472)
20. Osborn D. P. J., Wright C. A., Levy G., King M. B., Deo R., Nazareth I., Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis. BMC Psychiatry 2008 8, article 84 2-s2.0-54549127387 10.1186/1471-244X-8-84
21. Boekholdt S. M., Arsenault B. J., Mora S., Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. Journal of the American Medical Association 2012 307 1302 1309 10.1001/jama.2012.366
22. Choi S. Y., Kim D., Kang J. H., Park M. J., Kim Y. S., Lim S. H., Kim C. H., Lee H. S., Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis. The Korean Journal of Hepatology 2008 14 1 77 88 2-s2.0-58149121182
23. Targher G., Bertolini L., Padovani R., Poli F., Scala L., Tessari R., Zenari L., Falezza G., Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease. Diabetic Medicine 2006 23 4 403 409 2-s2.0-33645373311 10.1111/j.1464-5491.2006.01817.x
24. Targher G., Bertolini L., Padovani R., Rodella S., Tessari R., Zenari L., Day C., Arcaro G., Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007 30 5 1212 1218 2-s2.0-34247605492 10.2337/dc06-2247 (Pubitemid 46684650)
25. Targher G., Bertolini L., Poli F., Rodella S., Scala L., Tessari R., Zenari L., Falezza G., Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 2005 54 12 3541 3546 2-s2.0-33644700376 10.2337/diabetes.54.12.3541 (Pubitemid 43334347)
26. Assy N., Djibre A., Farah R., Grosovski M., Marmor A., Presence of coronary plaques in patients with nonalcoholic fatty liver disease. Radiology 2010 254 2 393 400 2-s2.0-77449127455 10.1148/radiol.09090769
27. Nseir W., Shalata A., Marmor A., Assy N., Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease. Digestive Diseases and Sciences 2011 56 12 3439 3449 2-s2.0-79957940100 10.1007/s10620-011-1767-y
28. Krawczyk M., Bonfrate L., Portincasa P., Nonalcoholic fatty liver disease. Best Practice and Research 2010 24 5 695 708 2-s2.0-77958103998 10.1016/j.bpg.2010.08.005
29. Lu H., Zeng L., Liang B., Shu X., Xie D., High prevalence of coronary heart sisease in type 2 diabetic patients with non-alcoholic fatty liver disease. Archives of Medical Research 2009 40 7 571 575 2-s2.0-71649109525 10.1016/j.arcmed.2009.07.009
30. Musso G., Gambino R., Cassader M., Pagano G., Meta-analysis: natural history of nonalcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Annals of Medicine 2011 43 617 649 10.3109/07853890.2010.518623
31. Alper A. T., Hasdemir H., Sahin S., Ontürk E., Akyol A., Nurkalem Z., Cakmak N., Erdinler I., Gürkan K., The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome. Türk Kardiyoloji Dernei Arşivi 2008 36 6 376 381 2-s2.0-68849103814
32. Targher G., Non-alcoholic fatty liver disease as a determinant of cardiovascular disease. Atherosclerosis 2007 190 1 18 19 2-s2.0-33845460005 10.1016/j.atherosclerosis.2006.06.004 (Pubitemid 44920234)
33. Bayturan O., Tuzcu E. M., Lavoie A., Hu T., Wolski K., Schoenhagen P., Kapadia S., Nissen S. E., Nicholls S. J., The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis. Archives of Internal Medicine 2010 170 5 478 484 2-s2.0-77950367419 10.1001/archinternmed.2009.551
34. Dunkley A. J., Charles K., Gray L. J., Camosso-Stefinovic J., Davies M. J., Khunti K., Effectiveness of interventions for reducing diabetes and cardiovascular disease risk in people with metabolic syndrome: systematic review and mixed treatment comparison meta-analysis. Diabetes, Obesity and Metabolism 2012 14 616 625 10.1111/j.1463-1326.2012.01571.x
35. Misra V. L., Khashab M., Chalasani N., Nonalcoholic fatty liver disease and cardiovascular risk. Current Gastroenterology Reports 2009 11 1 50 55 2-s2.0-58849118484 10.1007/s11894-009-0008-4
36. Obika M., Noguchi H., Diagnosis and evaluation of nonalcoholic fatty liver disease. Experimental Diabetes Research 2012 2012 12 145754 10.1155/2012/145754
37. Targher G., Day C. P., Bonora E., Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. The New England Journal of Medicine 2010 363 14 1341 1350 2-s2.0-77957375969 10.1056/NEJMra0912063
38. Ghouri N., Preiss D., Sattar N., Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology 2010 52 3 1156 1161 2-s2.0-77956631214 10.1002/hep.23789
39. Schindhelm R. K., Diamant M., Heine R. J., Nonalcoholic fatty liver disease and cardiovascular disease risk. Current Diabetes Reports 2007 7 3 181 187 2-s2.0-34250739374 10.1007/s11892-007-0030-6 (Pubitemid 46951915)
40. Moscatiello S., di Luzio R., Sasdelli A. S., Marchesini G., Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome. Expert Opinion on Pharmacotherapy 2011 12 657 2672 10.1517/14656566.2011.557360
41. Bhatia L. S., Curzen N. P., Byrne C. D., Nonalcoholic fatty liver disease and vascular risk. Current Opinion in Cardiology 2012 27 20 428